Physician profile
David P Lux
NPI 1174531651
$1,898.98
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $343 · 2021: $1,020 · 2022: $364.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $329.29 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $274.67 | 2019-2022 | |
| Glaxosmithkline, LLC. | $245.69 | 2019-2021 | |
| Amgen INC. | $223.61 | 2019-2022 | |
| Novo Nordisk INC | $157.61 | 2019-2022 | |
| Amarin Pharma, INC. | $112.33 | 2020-2021 | |
| Pfizer INC. | $81.33 | 2019-2022 | |
| Lilly USA, LLC | $64.60 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $60.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $42.75 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $39.97 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.20 | 2020-2021 | |
| Dexcom, INC. | $37.02 | 2022 | |
| Biogen, INC. | $32.55 | 2021 | |
| Bioventus LLC | $22.24 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofire Diagnostics, LLC | $21.05 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.52 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.78 | 2021 | |
| Astellas Pharma US INC | $12.22 | 2021 | |
| Sunovion Pharmaceuticals INC. | $11.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.75 | 2019 | |
| Radius Health, INC. | $11.67 | 2020 | |
| Avanir Pharmaceuticals, INC. | $11.58 | 2020 | |
| Daiichi Sankyo INC. | $11.42 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.